Case Updates
Third Circuit affirms dismissal of False Claims Act suit against pharmaceutical manufacturers, concluding that relator failed to sufficiently plead falsity and materiality as required by Fed. R. Civ. P. 9(b)
April 10, 2025
U.S. Chamber files coalition amicus brief urging Third Circuit to affirm dismissal of False Claims Act suit premised on a fraud-on-the agency theory that would require overriding the Food and Drug Administration's drug approval decisions
August 15, 2024
The brief argues that the suit failed to demonstrate falsity, materiality, or causation.
Douglas Hallward-Driemeier, Kellie Combs, and Beth Weinman of Ropes & Gray LLP served as outside counsel.